Orexigen Therapeutics, Inc.

Orexigen Therapeutics, Inc.

Orexigen Therapeutics, Inc.

Overview
Date Founded

2002

Headquarters

3344 North Torrey Pines Court, Suite 200, La Jolla, CA, 92037, USA

Type of Company

Public

Employees (Worldwide)

67

Industries

Pharmaceuticals
Hospitals & Patient Services
Biotechnology

Company Description

Mr. Keyes joined Orexigen in January 2013 as its Vice President of Finance. Prior to joining Orexigen, Mr. Keyes was at Amylin Pharmaceuticals, Inc. as Senior Director of Finance from May 2012 to January 2013 and Director, Manufacturing, Operations and Quality Finance from August 2007 to May 2012. Previously, he worked in financial and corporate strategy at Amgen, Inc. from March 2004 to July 2007, and at Baxter Healthcare Corporation from July 2002 to March 2004. Mr. Keyes holders a B.S. and M.S. in Civil Engineering from Stanford University and an M.B.A. from the Anderson School at the University of California, Los Angeles.

Contact Data
Trying to get in touch with decision makers at Orexigen Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Vice President & Chief Accounting Officer

Senior Vice President of Global Market Access & Development

Investor

Senior Director

Senior Director

Senior Director

Senior Director

Controller

Director

Director

Paths to Orexigen Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Orexigen Therapeutics, Inc.
Recent Transactions
Details Hidden

Pernix Therapeutics Holdings, Inc. purchases Orexigen Therapeutics, Inc.

Details Hidden

Orexigen Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Orexigen Therapeutics, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onOrexigen Therapeutics, Inc. raised money in a private placement transaction

Underwriter

Advised onOrexigen Therapeutics, Inc. issued Common Stock

Underwriter

Advised onOrexigen Therapeutics, Inc. issued Common Stock

Lead Manager

Advised onOrexigen Therapeutics, Inc. issued Common Stock

Legal Advisor

Advised onOrexigen Therapeutics, Inc. issued Common Stock

Professional

Advised onOrexigen Therapeutics, Inc. issued Common Stock

Advisors & Consultants
Legal Advisor

Partner at Latham & Watkins LLP

Legal Advisor

Partner, San Francisco at Cooley LLP

Consultant

President & Chief Executive Officer at Regulus Therapeutics, Inc.

Clients

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Takeda's ethical drugs are marketed in around 100 countries worldwide.

Key Stats and Financials As of
Market Capitalization
$161K
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
Investors
Details Hidden

Investor at Cyclacel Pharmaceuticals Inc.

Details Hidden

General Partner at Sofinnova Ventures, Inc.

Details Hidden

Montreux Equity Partners invests in commercial stage technology companies located in the US. The firm focuses on health technologies and health services sectors. The firm provides financing for seed, early, growth stage capital requirements with a revenue of $10 to $20 million per company with an initial investment size ranging from $10 to $20 million.

Suppliers
Oregon Health & Science University Hospitals & Patient Services | Portland, OR

Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. OHSU is the kind of place where the big news doesn't always involve sports, politics, fashion or even weather. The big news is always about health — health care, health education, health-related research. And various organizations and publications that rank American institutions, programs and faculty in a variety of categories have taken note. Nearly one million patient visits each year. Educating thousands of future health care providers. You get the picture. Immerse yourself in more facts and stats than you probably need about Portland's largest employer, Oregon's provider of care to every corner of the state, and one of the nation's top 28 biomedical research institutions. Oregon Health & Science University is the state’s only academic health center. It provides an uncommon array of services from providing the state’s most comprehensive health care, to educating the next generation of clinicians and biomedical researchers, to achieving breakthroughs and innovations.

University of Bath is a UK university with an international reputation for teaching and research excellence.

Thermo Fisher Scientific, Inc. Computer Software | Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Competitors
GlaxoSmithKline Plc Pharmaceuticals - Brentford, Middlesex

GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Roche Holding AG Pharmaceuticals - Basel, BS

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Novo Nordisk A/S Pharmaceuticals - Bagsværd, CR

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Orexigen Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Orexigen Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Orexigen Therapeutics, Inc..